FDA approves treatment for adult patients who have relapsed or refractory acute myeloid leukemia

Washington, DC - The U.S. Food and Drug Administration today approved Xospata (gilteritinib) tablets for the treatment of adult patients who have relapsed or refractory acute myeloid leukemia (AML) with a FLT3 mutation as detected by an FDA-approved test. The FDA also approved an expanded indication for a companion diagnostic, to include use with Xospata.

Treatment for preeclampsia effective in animals, NIH-funded researchers show

Washington, DC - In studies of mice and nonhuman primates, researchers funded by the National Institutes of Health have used a technique known as RNA interference to reduce high levels of a protein that can cause preeclampsia, a potentially fatal high blood pressure disorder of pregnancy.

NIMH Addresses Strategies for Suicide Prevention in Live Event

Washington, DC - What should you do if you are concerned a loved one may be thinking about suicide? According to the National Institute of Mental Health (NIMH) Director, Joshua Gordon, M.D., Ph.D., "the most important thing to do is to ask.”

Is My Child Overweight?

Yuma, Arizona - About 1 out of every 3 children in the US is overweight or obese. Because kids grow and mature on different schedules and have different body types, it’s not always easy to tell whether they’re at a healthy weight.

FDA moves to restrict sales of electronic cigarettes, but more can be done

Washington, DC - The American Heart Association, the leading voluntary health organization devoted to a world of longer, healthier lives, issued the following statement from CEO Nancy Brown in response to today’s Food and Drug Administration (FDA) announcement to limit access to flavored tobacco products: